Tags : Home

Lucira’s All-In-One Test Kit Receives the US FDA’s EUA as

Tuba Khan November 19, 2020

Shots: The Lucira’s COVID-19 all-in-one test kit test has been authorized for home use with self-collected nasal swab samples in individuals aged≥ 14yrs. who are suspected of COVID-19 by their […]readmore

DigiHealth

Takeda Collaborates with Enzyre to Develop Diagnostic Device to Regulate

Tuba Khan December 5, 2019

Shots: Enzyre to receive funding to advance its existing technology for the development of the diagnostic device, allowing hemophilia patients to automatically determine their coagulation status at home and transfer […]readmore

Tags : Home

Lucira’s All-In-One Test Kit Receives the US FDA’s EUA as

Takeda Collaborates with Enzyre to Develop Diagnostic Device to Regulate

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Home

Lucira’s All-In-One Test Kit Receives the US FDA’s EUA as

Takeda Collaborates with Enzyre to Develop Diagnostic Device to Regulate

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company